Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Us Weekly has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! If you’re tired of starting every year with the same gym membership you ...